David Jack
Obesity Medicine · Draper, UTNPI 1255434296
Payments from drug & device makers
Across 350 payments — averaging $3152.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$694K
- Eli Lilly$286K
- OPKO Pharmaceuticals, LLC$63K
- Boehringer Ingelheim$27K
- Pfizer$20K
- Boehringer Ingelheim International GmbH$6K
- plus $8K from 34 others
Across 14 payments — averaging $1094.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$14K
- AbbVie$1K
What the payments were for
- Speaking & faculty fees$601%
- Travel & lodging$2,42440%
- Food & beverage$3,50958%
- Education$922%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few obesity medicine providers in Utahto place this figure against a meaningful peer group, so we don't.
Other obesity medicine in Draper
- Thomas CheckettsSalt Lake City$462
- Nicholas TrujilloLehi$121
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.